These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19022933)

  • 1. Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid.
    Guarino MP; Carotti S; Morini S; Perrone G; Behar J; Altomare A; Alloni R; Caviglia R; Emerenziani S; Rabitti C; Cicala M
    Gut; 2008 Dec; 57(12):1740-1. PubMed ID: 19022933
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients.
    Carotti S; Guarino MP; Cicala M; Perrone G; Alloni R; Segreto F; Rabitti C; Morini S
    Neurogastroenterol Motil; 2010 Aug; 22(8):866-73, e232. PubMed ID: 20426797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects.
    Portincasa P; DiCiaula A; Palmieri V; Velardi A; Van Berge-Henegouwen GP; Palasciano G
    Ital J Gastroenterol; 1996; 28(2):111-3. PubMed ID: 8782006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
    Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
    Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones.
    Mas MR; Comert B; Mas N; Yamanel L; Ozotuk H; Tasci I; Jazrawi RP
    World J Gastroenterol; 2007 Aug; 13(32):4336-9. PubMed ID: 17708607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of black pigment gallstone formation after cardiac surgery by ursodeoxycholic acid.
    Abei M; Tanaka N
    J Gastroenterol; 2003; 38(11):1113-5. PubMed ID: 14673736
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonsteroidal antiinflammatory drugs and gallstone disease: will an aspirin a day keep the gallstones away?
    Sterling RK; Shiffman ML
    Am J Gastroenterol; 1998 Sep; 93(9):1405-7. PubMed ID: 9732915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis].
    Il'chenko AA; Drozhzhina IuV
    Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of gallbladder cholesterosis in children].
    Kharitonova LA; Ermolenko NS
    Eksp Klin Gastroenterol; 2014; (1):42-5. PubMed ID: 25518456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of combined application of ursosan and anxiolytic 2-mercaptobenzimidazole in early stage of cholelithiasis].
    Vakhrushev IaM; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2010; (4):105-8. PubMed ID: 20623958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gallstones and their complications.
    Ahmed A; Cheung RC; Keeffe EB
    Am Fam Physician; 2000 Mar; 61(6):1673-80, 1687-8. PubMed ID: 10750875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial.
    Guarino MP; Carotti S; Sarzano M; Alloni R; Vanni M; Grosso M; Sironi G; Maffettone PL; Cicala M
    Neurogastroenterol Motil; 2005 Oct; 17(5):680-6. PubMed ID: 16185306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis treated with ursodeoxycholic acid: three case reports.
    Itoh S; Kono M; Akimoto T
    Clin Exp Dermatol; 2007 Jul; 32(4):398-400. PubMed ID: 17376209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of gallstones by ursodeoxycholic acid after cardiac surgery.
    Ai T; Azemoto R; Saisho H
    J Gastroenterol; 2003; 38(11):1071-6. PubMed ID: 14673725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New approaches to diagnosis and treatment of cholelithiasis in young occupational groups].
    Preobrazhenskií VN; Vasilenko VV; Taianovski'i VI
    Klin Med (Mosk); 1997; 75(4):22-3. PubMed ID: 9229625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study.
    Berkhout M; Roelofs HM; Friederich P; van Schaik A; Gosens MJ; Marian B; Pool-Zobel BL; van Krieken JH; Peters WH; Nagengast FM
    Transl Res; 2007 Sep; 150(3):147-9. PubMed ID: 17761365
    [No Abstract]   [Full Text] [Related]  

  • 18. Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy.
    Giles F; Garcia-Manero G; Cortes J; Thomas D; Kantarjian H; Estey E
    Haematologica; 2002 Oct; 87(10):1114-6. PubMed ID: 12368170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sonography of gallbladder kinetics during cholagogue therapy].
    Tympner F
    Ultraschall Med; 1984 Jun; 5(3):131-3. PubMed ID: 6474147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursofalk.
    Williams CN
    Can J Gastroenterol; 1999 Nov; 13(9):717-8. PubMed ID: 10633823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.